Overcoming antibody blockade mechanisms associated with Th2-biased tumour conditions: Tumour-associated production of alternatively activated (e.g., IL-10-driven) rather than classically activated (IL-4-driven) Th2 environments may support local antibody class switching to inflammatory and immunologically inert subclasses such as IgG4. Here, IL10 is linked to neoplasm.